Continuous Glucose Monitoring in Metabolic Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
DiabetesObesity (Disorder)
Interventions
DEVICE

Abbot Freestyle Libre CGM

Participants assigned to the CGM group will receive the Libre 2+ systems (Abbott Diabetes Care, Alameda, CA) upon randomization. This will include comprehensive training provided by a qualified healthcare professional. The training will cover detailed instructions on sensor placement, how to download and use the associated smartphone application, and guidance on interpreting the glucose data effectively. To ensure continuous and accurate monitoring, the CGM sensor will be routinely replaced every 14 days following randomization. Additionally, in the event of sensor detachment or loss, immediate replacement will be arranged to maintain uninterrupted glucose tracking. Regular sessions are conducted to analyze glucose trends, refine management strategies, and provide additional support or education on device usage.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
collaborator

LA CaTS Clinical Research Resources Core

UNKNOWN

lead

Pennington Biomedical Research Center

OTHER